CENT vs FRPT: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CENT is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CENT and FRPT share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CENT and FRPT exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Central Garden & Pet sells the physical goods that keep a lawn alive and a pet fed. Two segments carry the whole company: Garden, which covers grass seed, wild bird feed, fertiliser, controls and pottery under names such as Pennington, Amdro and Sevin, and Pet, which spans aquatics, small animal and reptile supplies, dog and cat treats, flea and tick products and equine care under Kaytee, Aqueon, Farnam and Comfort Zone. Distribution runs mostly through big box retail, pet specialty chains, grocery and e-commerce, which is why the business is more sensitive to retailer inventory decisions and to a wet or dry spring than a typical packaged goods name. Fiscal 2025 net sales landed at ~$3.13B, and trailing twelve month sales sit at ~$3.08B after management deliberately exited a low margin pet distribution business.

Full CENT guide

Freshpet makes fresh, refrigerated food for dogs and cats and sells it through company-owned branded refrigerators placed inside retailers including Walmart, Target, Kroger, Costco, Publix, Petco, PetSmart and Tractor Supply. The model is unusual for a food company: Freshpet buys, installs, services and owns the fridge, which is both the distribution asset and the merchandising unit, and it manufactures nearly everything itself across three kitchen complexes in Bethlehem, Pennsylvania and Ennis, Texas. That vertical integration is why capital spending has run heavy for a decade (roughly $150 million planned in 2026) and why operating leverage arrives in steps rather than smoothly, as new lines come online and then fill up.

Full FRPT guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CENT drivers: The share class spread is the first variable, not a footnote; Central issues Class A, which quietly dilutes CENT's share of the equity.
• FRPT drivers: Household penetration and buy rate, not price; Capacity coming online at Ennis.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Governance is the structural risk specific to this ticker: a CENT holder owns one vote per share in a company where unlisted Class B holders may cast up to 49% of total votes, so minority influence over board composition or a change of control is limited by design. For FRPT, the competitive set changed in 2025 and 2026 and has not settled: The Farmer's Dog moved onto Walmart.com, Hill's launched a fresh line, and Costco introduced Kirkland fresh pet food, all attacking the premium position Freshpet built alone.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CENT if you believe its drivers more; FRPT if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CENT and FRPT guides.

CENT. One set of earnings supports two different multiples here, because CENT at ~$43.82 and CENTA at ~$38.20 divide the same ~$2.67 of trailing EPS. Screeners commonly quote a ~$2.7B market cap for Central by applying CENT's price to all ~62.6 million shares across every class, whereas valuing each class at its own quoted price puts the figure nearer ~$2.5B, a gap worth knowing before comparing Central's enterprise value of ~$3.15B or its ~9.5x EV/EBITDA against single class peers. Beta of ~0.54 and a ~5.4% net margin describe a low volatility, thin margin consumer goods business rather than a growth story.

FRPT. The gap between the operating result and the share price is the whole story here: the stock sits roughly 55% below its late-2024 peak while revenue, margins and cash flow have all improved. Reported net income figures are noisy because of tax valuation-allowance movements and a ~$4.5 million equity-investment gain in Q2 2026, so adjusted EBITDA is the cleaner comparison across periods. Anyone sizing the multiple should note that heavy capex means EBITDA overstates free cash flow, and that ~$150 million of annual capital spending is a real claim on it.

Headline figures (approximate, August 2026): CENT shows revenue (ttm) ~$3.08B, net income (ttm) ~$166M, diluted eps (ttm) ~$2.67, p/e on cent vs centa ~16.4x vs ~14.3x; FRPT shows revenue (ttm) ~$1.18 billion, with Q2 2026 net sales of ~$305.6 million, up ~15.5% year over year, 2026 guidance Net sales growth of ~10% to 12% (~$1.21 billion to $1.23 billion), raised in August 2026 from ~8% to 11%, adjusted ebitda ~$52.2 million in Q2 2026 (~17.1% margin); full-year guidance raised to ~$210 million to $220 million, margins Adjusted gross margin ~48.6% in Q2 2026 versus ~46.9% a year earlier; guided to improve ~100 to 150 basis points for the year.

CENT and FRPT are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CENT and FRPT exposure against your real portfolio. It is not an investment adviser.